%20logo.png)
The Alliance for Clinical & Translational Research (Alliance) is an island-wide network advancing health research in Puerto Rico and beyond. Supported by a grant from the National Institute of General Medical Sciences (NIGMS), the Alliance serves as a hub for expertise, resources, and innovation in clinical and translational research. The Alliance is led by the University of Puerto Rico Medical Sciences Campus (UPR-MSC) in partnership with Universidad Central del Caribe (UCC) and Ponce Health Sciences University (PHSU)/Ponce Medical School Foundation (PMSF). Together, we connect researchers, clinicians, and communities to translate discoveries into meaningful health outcomes.
Specialty
Areas
-
Specialty Area 1
-
Specialty Area 2
-
Specialty Area 3
Prioritized Clinical Trial Phases
-
Phase I
-
Phase II
-
Phase III
Trial Activation
Time
- Average turnaround time for Clinical Trial Agreements, Budget Negotiations, and IRB approval is 6 weeks
Site Highlights
-
Access to Practice Based Research through the NIH funded IDeA CTR (The Alliance)
​​
-
Collaborative work between researchers and the community through the community-academic partnerships (CAPS), that has increased visibility and helped in study design, recruitment and retention.
​​
- Variety of ongoing Research efforts include clinical trials in ALS, microbiome-focused clinical research, and initiatives led by the Cancer Research Center and Cancer Hospital.
​
Learn More about The Alliance
​​
-
To learn more and connect with the The Alliance, contact Sylvia Dávila